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Amaç: Dünya çap›nda en s›k görülen 4. malignite olan mide kanseri, Kuzey Bat› ‹ran'da bulunan Ardabil bölgesinde en s›k görü-
len kanserdir. Metilen tetrahidrofolat redüktaz, polimorfizmi belirgin olarak görülen kanser yatk›nl›k genlerinden birisidir. Meti-
len tetrahidrofolat redüktaz C677T, gen ürününün aktivitesini %30 azaltmakta ve kanser yatk›nl›¤›n› etkilemektedir. Gereç ve
Yöntem: Metilen tetrahidrofolat redüktaz C677T genotiplemesi, 76 gastrik kanserli ve 91 sa¤l›kl› kontrolde polimeraz zincir reak-
siyonu-restriksiyon parça uzunlu¤u polimorfizmi ile periferik kan DNA's›ndan yap›lm›ﬂt›r. ‹statistiksel anlaml›l›k lojistik regres-
yon analizi ile hesaplanm›ﬂt›r. Bulgular: Hastalar ve kontrol grubunda ortalama yaﬂ s›ras›yla 64.2±11.1 ve 62.1±9.8 idi. Tümör-
lerden %35.5'i yayg›n tipte di¤erleri intestinal tipte idi. Genotip frekanslar› Ala/Ala, Ala/Val, ve Val/Val genotipleri için hastalar
aras›nda %61.8, %32.9 ve %5.3 ve kontrol grubunda %45.1, %50.6 ve %4.4 idi. CT heterozigotlar, gastrik kanser aç›s›ndan daha
düﬂük yatk›nl›¤a sahipti (P=0.02). Bu anlaml› iliﬂki, yaﬂ ve cinsiyet dikkate al›narak bulunmuﬂtu. Sonuç: Ardabil bölgesinde T
alelinin yaﬂ ile koruyucu bir iliﬂkisi oldu¤u bulunmuﬂtur. 
Anahtar kelimeler: Gastrik kanser, metilen tetrahidrofolat redüktaz, C677T, Ardabil
Background/aims: Gastric cancer, as the fourth most frequent malignancy worldwide, has the highest rate among cancer-related
disorders in Ardabil province, located in North-West Iran. Methylene tetrahydrofolate reductase is one of the cancer susceptibility
genes with considerable polymorphisms. Methylene tetrahydrofolate reductase C677T leads to a decrease of about 30% in its pro-
duct activity and is reported to have an effect on cancer susceptibility. Materials and Methods: Methylene tetrahydrofolate reduc-
tase C677T genotyping was carried out by polymerase chain reaction-restriction fragment length polymorphism on peripheral blo-
od DNA from 76 gastric cancer patients and 91 healthy controls. The statistical significance was calculated by logistic regression
analysis. Results: The mean age was 64.2±11.1 and 62.1±9.8 years for cases and controls, respectively. Among tumors, 35.5% we-
re diffuse type and others were intestinal. The frequency of genotypes was 61.8%, 32.9%, and 5.3% among cases and 45.1%, 50.6%,
and 4.4% among controls for Ala/Ala, Ala/Val, and Val/Val, respectively. CT heterozygotes had lower susceptibility to gastric can-
cer (p=0.02). This relationship of significance was detected considering gender and age. Conclusions: It was found that T allele
has a protective association with age in the Ardabil province.  
Key words: Gastric cancer, methylene tetrahydrofolate reductase, C677T, Ardabil
ORIGINAL ARTICLE
Ardabil'de MTHFR C677T polimorfizmi ile gastrik kanser yatk›nl›¤›n›n 
azalmas›
INTRODUCTION
Gastric cancer is the fourth most frequent malig-
nancy worldwide and has been known as the se-
cond leading cause of cancer-related deaths (1,2).
In Iran, there is wide variation in gastric cancer
incidence among various areas. Ardabil province
is located in North-West Iran, and has been repor-
ted to have the highest incidence rate in the co-
untry, with an ASR (age-standardized  incidence
rate) of 49.1 and 25.4 in males and females, res-
pectively (3,4).
The cardia type has been detected in 36% of gas-
tric cancers in Ardabil, which is mentioned as the
highest rate recorded anywhere in the world (5).
Gastric cancer constituted about 33% of all cancer-
related deaths in this area (6,7). 
Gastric cancer susceptibility has been proven to be
associated with some genes, including TP53, DNA
repair system-related genes, interleukins, and
methylene tetrahydrofolate reductase (MTHFR).
Because of the interaction between genetic and en-
vironmental factors and diversities present in dif-
ferent environments, the importance of genetic va-
riations on cancer susceptibility could vary among
different populations.
Methylene tetrahydrofolate reductase (MTHFR) is
an enzyme involved in the metabolism of folate
and methyl groups. Reduction of 5, 10-methylene-
tetrahydrofolate to 5-methylenetetrahydrofolate
is catalyzed by MTHFR and involved in the rege-
neration of methionine from homocysteine. There-
fore, at least two processes are affected by MTHFR
activity. First, synthesis of nucleotides for DNA
replication, and thus proliferation capacity, and
second, DNA methylation associated with SAM,
the methyl donor form of methionine as a result of
MTHFR activity.
More than 29 mutations resulting in very low
MTHFR activity have been described in homocy-
stinuric patients (8). Indeed, two common poly-
morphisms, including C677T and A1298C, are re-
lated to MTHFR low activity. However, they were
seen in healthy individuals, and the reduced acti-
vity was not demonstrated in homocystinuric pati-
ents. Replacement of C by T in exon 4 at nucleoti-
de 677 leads to Ala222Val. Homozygous individu-
als for T nucleotide have only 30% activity compa-
red to CC individuals, and this level was 65% for
CT heterozygotes (9).
MTHFR C677T variation results in reduction in
enzyme activity (10,11). Therefore, conversion of
homocysteine to methionine is decreased and has
been shown by elevated levels of plasma homocy-
steine (12,13). This change tends to DNA hypo-
methylation, and thus affects regulation of some
genes. On the other hand, reductions in nucleotide
synthesis could have effects on decreasing cell pro-
liferation, which could be one of the mechanisms
of presenting a low risk for cancer susceptibility,
as shown in some previous reports (14-19).
The present report describes a case-control study
aimed to assay the effect of MTHFR C677T poly-
morphism on gastric cancer susceptibility in Arda-
bil province.
MATERIALS AND METHODS
Samples
Institutional guidelines including ethical and in-
formed consent were followed. Peripheral blood
samples from 76 patients with pathologically con-
firmed primary gastric cancer, resident in Ardabil
province, and 91 age-, sex-, and residency-matc-
hed healthy controls, without any cancer type-re-
lated family history, were selected and studied.
The assumable potential impacts of population
stratification bias in the studied participants were
estimated as previously described (13).
Genotyping
Genomic DNA from peripheral blood collected in
EDTA-coated tubes was extracted using QIAamp
Blood Mini Kit (Qiagen Co.). Genotyping was car-
ried out by polymerase chain reaction-restriction
fragment length polymorphism (PCR-RFLP).
The primers designed to amplify a fragment loca-
ted on exon 4 of the MTHFR gene were 5'-AGG
ACG GTG CGG TGA GAG TG-3' and 5'-TGA AGG
AGA AGG TGT CTG GGG GA-3'. The 198 bp amp-
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Cases Controls*
No 76 91
Age 64.2±11.1 62.1±9.8
≤50 Years 9 (11.8%) 9 (9.9%)
>50 Years 67 (88.2%) 82 (90.1%)
Gender
Male 56 (73.7%) 67 (73.6%)
Female 20 (25.3%) 24 (25.4%)
Tumor type
Diffuse 27 (35.5%)
Intestinal 59 (64.5%)
Table 1. General characteristics of participants
*Age-, sex-, place of residence-adjusted population
lified fragment was digested by HinfI
(Fermentas Co.). An uncut fragment
indicates allele C (coding for Ala ami-
no acid). However, substitution of C
by T tends to create a HinfI restricti-
on site. Therefore, alleles T (coding for
Val) are observed by 175 and 23 bp di-
gested products.  If the quantity of
restriction enzyme used is inadequa-
te, the homozygous digested results
may be detected as heterozygote. The-
refore, some sequenced samples were
chosen for evaluating the accuracy of
digestion. 
RESULTS
The mean age of the patient group
was 64.2 years (range, 40-84 years),
and there were no statistically signifi-
cant differences in the distributions
of age and gender between cases and
controls. Participants of the two gro-
ups had the same residency and were
born and resided in Ardabil. The me-
an age of controls was 62.1 years
(range, 44-81 years). The characteris-
tics of the participants are presented
in Table 1.
Table 2 shows the distribution of
MTHFR C677T genotypes and their
statistical relationships with sex, age,
and tumor type among the case and
control groups. The distribution of
this polymorphism in the control gro-
up was in Hardy-Weinberg equilibri-
um. The frequency of genotypes for
Ala/Ala, Ala/Val, and Val/Val was
61.8%, 32.9%, and 5.3% among gas-
tric cancer cases and 45.1%, 50.6%,
and 4.4% among healthy controls,
respectively.  
Compared with CC homozygotes, CT
heterozygotes had lower susceptibi-
lity to develop cancer (odds ratio
[OR]=0.47; 95% confidence interval
[CI]=0.25-0.90). The CT was signifi-
cantly correlated with a reduced risk
in females (OR=0.17; 95%CI=0.04-
0.72) and older participants
(OR=0.45; 95%CI=0.23-0.90). Among
27 cases with diffuse type tumor, CT
genotype conferred a lower risk of
MTHFR C677T and gastric cancer
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cancer (OR=0.33; 95%CI=0.13-0.87). However, dis-
tribution of genotypes among male and young par-
ticipants and patients with intestinal type tumor
showed no significant association (Table 2).
DISCUSSION
The high incidence of gastric cancer in Ardabil
province, Iran, encouraged us to follow the predis-
position and susceptibility factors, including gene
polymorphisms. The polymorphism C677T in the
MTHFR gene was one of the attractive assays.
Genetic polymorphisms leading to folate defici-
ency seem to have effects on the tumorigenesis of
some types of cancers. Folate, as a part of DNA
methylation, has several functions including con-
trolling expression of some genes and chromatin
and genome stabilization. The polymorphism
MTHFR C677T results in a reduction in enzyme
activity. Considering the low capacity of DNA rep-
lication offered by substituting C by T, this poly-
morphism should effect a reduction in cancer risk.
However, focusing on the effects of this reduced
activity of the enzyme on uncontrolled gene ex-
pression and genome stability, an increase in the
risk of cancer could be expected.
There is considerable geographic and ethnic vari-
ation in the distribution of this polymorphism.
The genotype TT distribution ranges from 1% in
blacks to over 20% in Europeans, Colombians, and
American Indians (20,21). 
The results of an association between this poly-
morphism and gastric cancer have been quite in-
consistent. Some results including three meta-
analyses showed TT genotype as a risk factor for
gastric cancer (15,16,19,22-27). Despite finding an
association in some studies (28-30), others have
emphasized the decreased risk caused by the
C677T polymorphism (31-33).
Our results showed a significant association bet-
ween allele T and decreased risk of gastric cancer.
In spite of no statistically significant association
for T homozygotes (TT vs. CC), CT heterozygotes
revealed this association (OR=0.47; 95%CI= 0.25-
0.90), which was consistent with a valuable study
in the Korean population (32), as did patients
carrying allele T (CT and TT vs. CC: OR=0.5;
95%CI= 0.27-0.93), as support for the previous fin-
ding (33).
The higher frequency of older patients determined
in the present investigation (88.2%) was conside-
rable. It could suggest that genetic changes are less
important than environmental factors in gastric tu-
morigenesis in Ardabil, as described previously (7).
As well as the low number of participants, other
factors affecting on our results are some nutrients
involved in the folate metabolic pathway, alcohol
and smoking. Alcohol is a folate antagonist and
smoking impairs the folate level. They could inte-
ract with folate levels, and therefore, have effects
on cancer risk induced by the MTHFR polymorp-
hism (34,35). The inverse association between fo-
late intake and plasma homocysteine levels can be
modified by alcohol intake and by MTHFR poly-
morphism (22,36). Inclusion of data regarding die-
tary habits, alcohol intake (which is not common
among our population) and smoking could increa-
se the accuracy of our results.
The inconsistency observed among different popu-
lations could result from different ethics, dietary
habits and environmental factors.
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